Organovo - ONVO Total Company Value-to-Revenue Ratio

Organovo (ONVO) - corporate logo

Organovo Holdings, Inc. (ONVO) relies on a staff of specialized bioprinters with minimal employee turnover. The EV/Sales multiple trajectory demonstrates the asset's current dynamics, where shows the value of this parameter. The NovoGen platform for B2B testing creates growth potential, however, geopolitical fragmentation and trade barriers limit the expansion of 3D printing technologies into global markets.

ONVO Organovo Holdings, Inc.: Enterprise Value-to-Revenue Ratio in the range 07/04/2022 - 11/22/2026

ONVO (Organovo Holdings Inc): analytical breakdowns and indicator data

Fundamental company valuation:ONVO Organovo Holdings, Inc.
Core merchandise of Organovo Holdings

The EV/Sales ratio determines the total enterprise value, including debt, relative to generated revenue, allowing for an assessment of the market premium paid per unit of sales. By analyzing the EV/Sales ratio, an investor can see the impact of venture capital on Organovo Holdings, Inc. (ONVO), whose capitalization is currently driven by FDA expectations and the success of 3D liver bioprinting rather than current laboratory revenues.

Competitor analysis for Organovo Holdings, Inc.

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Rhythm Corp|Akero Corp (AKRO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio metsera.com (MTSR)|Company Value to Revenue moonlaketx.com MLTX|EV/Sales Multiple CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Company Value to Revenue Ratio|SLNO - Enterprise Value-to-Revenue Ratio|Amicus Pharma (FOLD) - Company Value to Revenue|ETNB: EV/Sales Multiple|AGIO - Total Company Value-to-Revenue Ratio|Company Value to Revenue GPCR|Enterprise Value-to-Revenue Multiple MiMedx MDXG|Enterprise Value-to-Revenue Ratio Rezolute Corp (RZLT)|Company Value to Revenue Lexicon Corp LXRX|Enterprise Value-to-Revenue Ratio MBX Biosciences, Inc. MBX|EV/Sales Multiple altimmune.com ALT|AARD - Enterprise Value-to-Revenue Ratio|Sagimet - Enterprise Value-to-Revenue Coefficient|BioAge Labs Inc. (BIOA) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - EV/Sales Multiple|GUTS: Business Value to Revenue|Enterprise Value-to-Revenue Ratio vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Pluristem Therapeutics PLUR|SYBX: Company Value to Revenue Ratio|lipocine.com - EV/Sales Multiple|Enterprise Value to Sales Volume MTNB|SPRB: EV/Sales Multiple|Enterprise Value-to-Sales Ratio Galecto Inc GLTO|Enterprise Value-to-Revenue Ratio Carmell Corp|Lumos Therapeutics (LUMO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Radius Recycling (RDUS)